Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:spironolactone
|
| gptkbp:approvalYear |
2017
|
| gptkbp:ATCCode |
C03DA01
|
| gptkbp:contraindication |
Addison's disease
hyperkalemia anuria |
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:form |
oral suspension
|
| https://www.w3.org/2000/01/rdf-schema#label |
Carospir
|
| gptkbp:indication |
heart failure
edema hypertension primary hyperaldosteronism |
| gptkbp:manufacturer |
CMP Pharma
|
| gptkbp:mechanismOfAction |
aldosterone antagonist
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:regulates |
approved
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
drowsiness
gynecomastia hyperkalemia gastrointestinal disturbances menstrual irregularities |
| gptkbp:bfsParent |
gptkb:spironolactone
|
| gptkbp:bfsLayer |
7
|